A detailed history of Fortitude Family Office, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Fortitude Family Office, LLC holds 310 shares of CMRX stock, worth $272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
310
Previous 310 -0.0%
Holding current value
$272
Previous $272,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$0.87 - $1.05 $87 - $105
100 Added 47.62%
310 $272,000
Q4 2023

Jan 12, 2024

BUY
$0.9 - $1.06 $189 - $222
210 New
210 $202,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.